MANTLE CELL LYMPHOMA (MCL) - A CYTOPATHOLOGICAL AND IMMUNOCYTOCHEMICAL STUDY

被引：0
|
作者：
HIJAZI, Y [1 ]
GAGNETEN, D [1 ]
SOLOMON, D [1 ]
机构：
[1] NATL INST HLTH,BETHESDA,MD
来源：
LABORATORY INVESTIGATION | 1994年 / 70卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [31] The Tumor Microenvironment in Mantle Cell Lymphoma (MCL): Novel Targets to Overcome Chemo-Resistance in MCL
    Pham, Lan V.
    Tamayo, Archito T.
    Pogue, Elizabeth
    Lu, Gary
    Challagundla, Pramoda
    Jorgensen, Jeffrey L.
    Zhang, Liang
    Wang, Michael
    Ford, Richard J.
    BLOOD, 2014, 124 (21)
  • [32] Dual Targeting of NOXA/MCL-1 Synergistically Induces Cell Death in Mantle Cell Lymphoma (MCL) Cells
    Hoering, Elisabeth
    Ott, German
    Bayha, Christine
    Markus, Kleih
    Voehringer, Matthias C.
    van Der Kuip, Heiko
    Aulitzky, Walter E.
    BLOOD, 2015, 126 (23)
  • [33] Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation
    Shanbhag, Satish
    Smith, Mitchell R.
    Emmons, Robert V. B.
    STEM CELLS AND CLONING-ADVANCES AND APPLICATIONS, 2010, 3 : 93 - 102
  • [34] EUROPEAN-LYMPHOMA-TASK-FORCE (ELTF) - REPORT OF THE WORKSHOP ON MANTLE CELL LYMPHOMA (MCL)
    ZUCCA, E
    STEIN, H
    COIFFIER, B
    ANNALS OF ONCOLOGY, 1994, 5 (06) : 507 - 511
  • [35] Mantle-cell lymphoma (MCL) in leukemic phase (''MC leukemia''): A study of 14 cases.
    Rozman, M
    Bosch, F
    Villamor, N
    Campo, E
    Rozman, C
    Montserrat, E
    BLOOD, 1996, 88 (10) : 888 - 888
  • [36] Bortezomib in patients with relapsed or refractory mantle cell lymphoma (MCL): Preliminary results of the PINNACLE study.
    Goy, A
    Bernstein, S
    Kahl, B
    Epner, E
    Leonard, JP
    Stadtmauer, E
    Morgan, D
    Belt, R
    Baidas, S
    Fisher, RI
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 575S - 575S
  • [37] Gastrointestinal involvement in mantle cell lymphoma (MCL).: A prospective clinical, endoscopical, pathological and molecular study.
    Salar, A
    Juanpere, N
    Gonzalez-Barca, E
    Bellosillo, B
    Espinet, B
    Seoane, A
    Panadés, A
    Romagosa, V
    Pedro, C
    Nieto, M
    Abella, E
    Domingo-Domenech, E
    Sole, F
    Fernandez-Sevilla, A
    Besses, C
    Serrano, S
    BLOOD, 2005, 106 (11) : 246B - 246B
  • [38] "In Situ" Mantle Cell Lymphoma (MCL), an Incidental Finding with an Indolent Clinical Course
    Carvajal, A.
    Sua, L.
    Silva, N.
    Pittaluga, S.
    Royo, C.
    Sargent, R. L.
    Climent, F.
    Jacobs, S. A.
    Delabie, J.
    Naresh, K.
    Bagg, A.
    Harris, N. L.
    Swerdlow, S. H.
    Jaffe, E. S.
    Campo, E.
    LABORATORY INVESTIGATION, 2011, 91 : 289A - 289A
  • [39] JAK/STAT3 signaling pathway in mantle cell lymphoma (MCL)
    Yared, MA
    Medeiros, LJ
    Khoury, JD
    Rassidakis, GZ
    Leventaki, V
    Lai, R
    MODERN PATHOLOGY, 2003, 16 (01) : 260A - 261A
  • [40] PREVALENCE AND TREATMENT OF MANTLE CELL LYMPHOMA (MCL) IN GERMANY: AN ANALYSIS OF SICKNESS FUNDS
    Tomeczkowski, J.
    Leisten, M. K.
    Metin, H.
    Fleischmann, J.
    Tapprich, C.
    HAEMATOLOGICA, 2015, 100 : 777 - 777
12345